|
Market Closed -
Nasdaq
16:00:00 2026-10-22 EDT
|
5-day change | 1st Jan Change | ||
| 25.51 USD | -1.96% |
|
+2.24% | +34.48% |
| 10-14 | Nurix Therapeutics Insider Sold Shares Worth $528,528, According to a Recent SEC Filing | MT |
| 10-13 | Nurix Therapeutics' Enterprise Value Remains Underappreciated, RBC Capital Markets Says | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.96% | +2.24% | -0.62% | +8.09% | +34.48% | +139.98% | +433.68% | -9.06% | - | 2.79B | |
| -4.10% | -8.54% | -15.81% | +12.24% | +55.90% | +40.05% | +66.99% | +1.09% | - | 63.29B | |
| -0.23% | +7.37% | -6.53% | -1.98% | +8.98% | +10.87% | +73.25% | +212.98% | +5,389.81% | 54.89B | |
| -0.03% | +3.97% | +11.78% | +15.82% | +16.77% | +9.41% | +91.70% | -16.31% | +247.54% | 53.28B | |
| +0.61% | +2.69% | +3.05% | +40.20% | +23.47% | +27.75% | +50.97% | +8.34% | +276.01% | 45.81B | |
| -1.08% | +2.19% | +3.86% | +19.49% | +25.83% | +21.92% | +131.38% | +0.89% | +1,053.85% | 43.46B | |
| -3.39% | -0.83% | -2.68% | +2.55% | +135.64% | +254.27% | +571.04% | +587.51% | - | 40.23B | |
| -1.67% | +6.70% | +8.85% | +14.23% | +12.72% | +14.42% | +56.67% | +7.67% | +160.85% | 33.45B | |
| +1.19% | -4.98% | -13.26% | +16.72% | +45.67% | +29.01% | -0.76% | -61.09% | - | 23.7B | |
| -1.09% | +4.92% | +14.53% | +37.87% | +29.50% | +35.45% | +26.63% | -12.06% | +129.46% | 23.76B | |
| -1.77% | -0.59% | -11.10% | -2.35% | -5.81% | -15.59% | -1.36% | -67.78% | - | 22.53B | |
| +1.08% | -4.18% | -21.32% | -10.86% | -45.38% | -40.74% | +279.03% | +246.30% | +577.07% | 20.76B | |
| -1.29% | +4.03% | +3.77% | +23.83% | +16.44% | +19.61% | +185.26% | +249.64% | +1,989.33% | 18.29B | |
| -1.51% | +10.91% | +19.13% | +55.31% | +70.27% | +81.64% | +83.19% | -19.25% | +313.56% | 16.21B | |
| +1.13% | +3.95% | +12.31% | +18.79% | +49.01% | +81.01% | +209.38% | +205.19% | +464.97% | 16.18B | |
| +0.17% | +6.57% | +9.51% | +26.13% | +33.65% | +33.14% | +76.88% | -18.95% | +94.79% | 16.19B | |
| +1.71% | +7.22% | +2.28% | -3.55% | - | - | - | - | - | 15.69B | |
| -1.28% | -3.73% | 0.00% | -1.69% | +173.78% | +150.34% | +360.63% | +1,403.12% | +739.98% | 14.74B | |
| +2.81% | +1.86% | -4.68% | -11.72% | +17.39% | +7.82% | +539.00% | - | - | 13.66B | |
| +0.10% | +5.88% | +10.96% | +10.85% | +1.76% | -3.72% | -18.21% | -33.18% | +119.34% | 14.29B | |
| Average | -0.53% | +1.45% | +1.20% | +13.50% | +36.85% | +47.19% | +169.23% | +149.17% | +888.96% | 27.66B | |
| Weighted average by Cap. | -0.88% | +1.04% | -0.07% | +14.08% | +36.12% | +42.96% | +140.33% | +123.13% | +1,214.67% |
- Stock Market
- Stocks
- NRIX Stock
- Sector Nurix Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
